For Plastic Surgeons, Learning ‘Danger Zones’ Can Increase Safety When Using Facial Fillers

Dermal fillers have become a popular alternative to surgery for patients who want a younger facial appearance. Learning about some key “danger zones” can help plastic surgeons to enhance the safety and effectiveness of facial filler procedures, according to an expert update in the May issue of Plastic and Reconstructive Surgery®, the official medical journal of the American Society of Plastic Surgeons (ASPS).

The article is written by Rod J. Rohrich, MD, and colleagues from the Dallas Plastic Surgery Institute. Rohrich also serves as editor-in-chief of Plastic and Reconstructive Surgery®. The article is accompanied by a set of online videos illustrating anatomically-based techniques to minimize risk and maximize safety when using dermal fillers in specific areas of the face.

“Given current trends, it becomes even more important that plastic surgeons, dermatologists, oculoplastic surgeons and facial plastic surgeons learn safe, predictable techniques to achieve optimal results with facial filler injections,” said Dr. Rohrich.

Videos Illustrate ‘Danger Zones’ in Facial Filler Injection
Injection of soft tissue dermal fillers can reduce facial lines and wrinkles and restore a fuller, younger-looking facial appearance. Providing immediate results with a short recovery time, dermal filler injection has become the second-most popular nonsurgical cosmetic procedure (behind botulinum toxin injection). According to ASPS statistics, more than 2.6 million dermal filler procedures were performed in 2016.

When performed by a board certified or experienced practitioner facial filler injection is a safe procedure. Complications are uncommon and generally mild. However, rare but serious complications have been reported, occurring especially with inadvertent injection blood vessel damage or injection of the filler material into the blood vessels.

Dr. Rohrich outlines his approach to specific principles for safe filler injection, including the use of hyaluronic acid fillers when possible. The major advantage of these products is that their effects can be rapidly reversed by rescue injection with the enzyme hyaluronidase. Of the 2.6 million dermal filler procedures performed last year, 2 million were completed using hyaluronic acid fillers. Other principles for safe filler injection include the use of continuous motion and gentle injection techniques.

“Most importantly, practitioners should be able to recognize complications and address them immediately,” Dr. Rohrich said. “They should pay particular attention to the six danger zones from the forehead to the chin, areas commonly addressed by facial filler injection.”

In the online videos, Dr. Rohrich demonstrates and narrates his approach to dermal filler injection in each area. He explains the steps to protect the underlying blood vessels, while discussing the filler products and injection techniques to achieving the best results in each area. The videos also include cadaver dissections demonstrating the course of the underlying blood vessels in each danger zone, as well as before-and-after views showing the facial rejuvenation results.

Plastic and Reconstructive Surgery® is published by Wolters Kluwer.

Click here to read “Facial Danger Zones: Techniques to Maximize Safety during Soft-Tissue Filler Injections”

Article: “Facial Danger Zones: Techniques to Maximize Safety during Soft-Tissue Filler Injections” (doi: 10.1097/PRS.0000000000003309)

About Plastic and Reconstructive Surgery

For more than 70 years, Plastic and Reconstructive Surgery® has been the one consistently excellent reference for every specialist who uses plastic surgery techniques or works in conjunction with a plastic surgeon. The official journal of the American Society of Plastic Surgeons, Plastic and Reconstructive Surgery® brings subscribers up-to-the-minute reports on the latest techniques and follow-up for all areas of plastic and reconstructive surgery, including breast reconstruction, experimental studies, maxillofacial reconstruction, hand and microsurgery, burn repair, and cosmetic surgery, as well as news on medico-legal issues.

About ASPS

The American Society of Plastic Surgeons (ASPS) is the world’s largest organization of board-certified plastic surgeons. Representing more than 7,000 Member Surgeons, the Society is recognized as a leading authority and information source on aesthetic and reconstructive plastic surgery. ASPS comprises more than 94 percent of all board-certified plastic surgeons in the United States. Founded in 1931, the Society represents physicians certified by The American Board of Plastic Surgery or The Royal College of Physicians and Surgeons of Canada. ASPS advances quality care to plastic surgery patients by encouraging high standards of training, ethics, physician practice and research in plastic surgery.

About Wolters Kluwer

Wolters Kluwer is a global leader in professional information services. Professionals in the areas of legal, business, tax, accounting, finance, audit, risk, compliance and healthcare rely on Wolters Kluwer’s market leading information-enabled tools and software solutions to manage their business efficiently, deliver results to their clients, and succeed in an ever more dynamic world.

Wolters Kluwer reported 2015 annual revenues of €4.2 billion. The group serves customers in over 180 countries, and employs over 19,000 people worldwide. The company is headquartered in Alphen aan den Rijn, the Netherlands. Wolters Kluwer shares are listed on Euronext Amsterdam (WKL) and are included in the AEX and Euronext 100 indices. Wolters Kluwer has a sponsored Level 1 American Depositary Receipt program. The ADRs are traded on the over-the-counter market in the U.S. (WTKWY).

Wolters Kluwer Health is a leading global provider of information and point of care solutions for the healthcare industry. For more information about our products and organization, visit www.wolterskluwer.com, follow @WKHealth or @Wolters_Kluwer on Twitter, like us on Facebook, follow us on LinkedIn, or follow WoltersKluwerComms on YouTube.